Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contezolid in Tuberculous Meningitis
NCT06811025Phase 2Enrolling by invitation
- Sponsor
- Beijing Chest Hospital
- Start
- Feb 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of contezolid in tuberculous meningitis (TBM), sponsored by Beijing Chest Hospital. Started Feb 2024; status: enrolling by invitation.
02
Drugs
contezolid
03
Conditions
tuberculous meningitis (TBM)
Beyond the preview
Go deeper on NCT06811025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06811025.